pc semaglutide/glycine Semaglutide with glycine: The complete guide Standard Dose Compounded Semaglutide +

Skip the subscription

In February 2025, following review of the TRAVERSE data, the FDA removed the cardiovascular black-box warning from testosterone products

GLP-1s (glucagon-like peptide-1 receptor agonists), also known as incretin mimetics, are a class of prescription medications that have been proven to be effective in the treatment of type 2 diabetes and in support of weight loss

While many insurers will cover GLP-1 drugs when prescribed for diabetes or other conditions such as heart disease or sleep apnea, more than half of employer insurance plans have refused to cover the medications solely for obesity

"There are some [people] that, despite doing all of this, might have difficulty losing weight, and for those, I recommend talking to a provider to review the variety of medications and interventions that might help."

Nothing is added later